Fonseca HAndrade R, Fonseca FA, Lins íviaC, Monteiro AM, Bianco HT, ão SA, Povoa RM, Juliano L, Figueiredo-Neto ônioM, Boschcov P et al..  2015.  Antihypertensive therapy increases natural immunity response in hypertensive patients. Life Sciences. 143:124-130.

Cabral-Miranda G, Gidlund M, M. Sales GF.  2014.  Backside-surface imprinting as a new strategy to generate specific plastic antibody materials. Journal of Materials Chemistry B. 2(20):3087.

Moreira FTocci, Ramos SCristina, Monteiro AMoreira, Helfenstein T, Gidlund M, Damasceno NRaquel Tei, Neto AMartins Fi, Izar MCristina, Fonseca FAntonio He.  2014.  Effects of two lipid lowering therapies on immune responses in hyperlipidemic subjects. Life Sciences. 98(2):83-87.

Ramos-Sanchez EMilton, Goto H, Rivero DHelena Rod, Mauad T, de Souza FNogueira, Monteiro AMoreira, Gidlund M.  2014.  In vivo assessment of antiretroviral therapy-associated side effects. Memórias do Instituto Oswaldo Cruz. 109(4):484-487.

Cabral-Miranda G, Yamashiro-Kanashiro E.HG, Gidlund M, M. Sales GF.  2014.  Specific label-free and real-time detection of oxidized low density lipoprotein (oxLDL) using an immunosensor with three monoclonal antibodies. J. Mater. Chem. B. 2(5):477-484.

Orellana RVargas, Fonseca HAndrade Ro, Monteiro AMoreira, Ortega KLopes, Gallottini MHelena, Gidlund M, Pobocik AMantesso.  2013.  Association of autoantibodies anti-OxLDL and markers of inflammation with stage of HIV infection. International Journal of Cardiology. 168(2):1610-1612.

ço ériaS, Kodaira áudiaA, Ramos-Sanchez EM, Felinto áudiaFC, Goto H, Gidlund M, Malta OL, Brito HF.  2013.  Luminescent material based on the [Eu(TTA)3(H2O)2] complex incorporated into modified silica particles for biological applications. Journal of Inorganic Biochemistry. 123:11-17.

Fonseca HAndrade R, Fonseca FA, Monteiro AM, Bianco HT, Boschcov P, ão SA, Juliano L, Gidlund M, Izar MC.  2013.  Obesity Modulates the Immune Response to Oxidized LDL in Hypertensive Patients. Cell Biochemistry and Biophysics. 67(3):1451-1460.

Rios FJ, Koga MM, Pecenin M, Ferracini M, Gidlund M, Jancar S..  2013.  Oxidized LDL Induces Alternative Macrophage Phenotype through Activation of CD36 and PAFR. Mediators of Inflammation. 201329031(4):1-8.

da Cunha J, Maselli LMorganti F, Treitinger ïcio, Monteiro AMoreira, Gidlund M, ão RCavalcanti, Spada C, Bydlowski érgioPaulo.  2013.  Serum levels of IgG antibodies against oxidized LDL and atherogenic indices in HIV-1-infected patients treated with protease inhibitors. Clinical Chemistry and Laboratory Medicine. 51(2)

Sicchieri íciaBonfante, Monteiro AMoreira, Samad RElgul, Ito ASiuiti, Neto AMartins Fi, Vieira NDias, Gidlund M, Courrol LCoronato.  2013.  Study of Tryptophan Lifetime Fluorescence Following Low-Density Lipoprotein Modification. Applied Spectroscopy. 67(4):379-384.

Parra E, Panzoldo ália, Kaplan D, de Oliveira HCoutinho, é Santos dos, de Carvalho érgio, Sposito A, Gidlund M, Nakamura R, Zago Vde Souza et al..  2012.  The I405V and Taq1B polymorphisms of the CETP gene differentially affect sub-clinical carotid atherosclerosis. Lipids in Health and Disease. 11(1):130.

da Fonseca HAndrade Ro, Fonseca FAntonio He, Monteiro AMoreira, Farias NCarvalho, Bianco HTria, ão SAugusto Bu, óvoa RManoel dos, Gidlund M, Izar MCristina d.  2012.  Inflammatory environment and immune responses to oxidized LDL are linked to systolic and diastolic blood pressure levels in hypertensive subjects. International Journal of Cardiology. 157(1):131-133.

Monteiro éaM, Jardini MAN, Giampaoli V, Alves S, Neto ônioMFigueir, Gidlund M.  2012.  Measurement of the nonlinear optical response of low-density lipoprotein solutions from patients with periodontitis before and after periodontal treatment: evaluation of cardiovascular risk markers. Journal of Biomedical Optics. 17(11):115004.

Souza FN, Monteiro AM, Santos PR dos, Sanchez EMRamos, Blagitz MG, Latorre éiaO, Neto ônioMFigueir, Gidlund M, Libera AMMPDel.  2011.  Antioxidant status and biomarkers of oxidative stress in bovine leukemia virus-infected dairy cows. Veterinary Immunology and Immunopathology. 143(1-2):162-166.

Kodaira áudiaA, ço ériaS, Felinto áudiaFC, Sanchez EMR, Rios FJO, Nunes LAntonio O, Gidlund M, Malta OL, Brito HF.  2011.  Biolabeling with nanoparticles based on Y2O3: Nd3+ and luminescence detection in the near-infrared. Journal of Luminescence. 131(4):727-731.

Teixeira Ldos Santos, Grasso éaNastri, Monteiro AMoreira, Neto AMFigueir, Vieira NDias, Gidlund M, Steffens J, Courrol LCoronato.  2011.  Investigation of the Europium Emission Spectra of the Europium-Oxytetracycline Complex in the Presence of Human Low-Density Lipoproteins. Journal of Fluorescence. 21(3):887-892.

Rios FJO, Gidlund M, Jancar S.  2011.  Pivotal Role for Platelet-Activating Factor Receptor in CD36 Expression and oxLDL Uptake by Human Monocytes/Macrophages. Cellular Physiology and Biochemistry. 27(3-4):363-372.

Castanho VSylvia, Gidlund M, Nakamura R, de Faria ECotta.  2011.  Post-menopausal hormone therapy reduces autoantibodies to oxidized apolipoprotein B100. Gynecological Endocrinology. 27(10):800-806.

Mello APaula de Q, da Silva ITande, Oliveira ASilva, Nunes ériaSutti, Abdalla DSaes Parra, Gidlund M, Damasceno ágilaRaquel Tei.  2010.  Electronegative Low-Density Lipoprotein is Associated with Dense Low-Density Lipoprotein in Subjects with Different Levels of Cardiovascular Risk. Lipids. 45(7):619-625.

Teixeira Ldos Santos, Grasso éaNastri, Monteiro AMoreira, Neto A.M.Figueiredo, Vieira NDias, Gidlund M, Courrol LCoronato.  2010.  Enhancement on the Europium emission band of Europium chlortetracycline complex in the presence of LDL. Analytical Biochemistry. 400(1):19-24.

Carvalho árciaDias Teixe, Vendrame éliaMaria Viei, Ketelhuth DFrancisco, Yamashiro-Kanashiro EHatsumi, Goto H, Gidlund M.  2010.  High-Density Lipoprotein Inhibits the Uptake of Modified Low- Density Lipoprotein and the Expression of CD36 and FcγRI. Journal of Atherosclerosis and Thrombosis. 17(8):844-857.

Rosoky RMiguel Ayz, Wolosker N, Nasser M, Zerati AEduardo, Gidlund M, ão P.  2010.  Oxidized low-density lipoprotein and ankle-brachial pressure index in patients with clinically evident peripheral arterial disease. Clinics. 65(4):383-387.